Jump to content
RemedySpot.com

article

Rate this topic


Guest guest

Recommended Posts

Subscribe now>> <http://main.diabetes.org/site/R?i=h8tdI7yVGx5i46rX4GqndA..>

Anti-obesity Pill Reduces Weight, Improves Lipids In a two-year study of

overweight or obese subjects, a marijuana derivative, or cannabinoid, called

rimonabant (Acomplia) helped those who took it lose weight and improve their

cardiovascular risk profile. Weight loss occurred after one year of taking

the drug and was sustained over a second year if treatment was continued.

The agent also improved cardiometabolic risk factors even more than the

amount of weight loss would have predicted.

" Our observations collectively suggest that rimonabant may well represent an

innovative approach to the management of multiple cardiometabolic risk

factors, " the authors write in the Journal of the American Medical

Association. Dr. F. Xavier Pi-Sunyer, from St. Luke's-Roosevelt Hospital in

New York, and his associates initially randomized 607 subjects to placebo,

1214 to rimonabant 5 mg, and 1219 to rimonabant 20 mg, while advising them

to reduce their calorie intake by approximately 600 kcal/day and to increase

physical activity.

Learn more>> <http://main.diabetes.org/site/R?i=h5y93DXTODFEzwqZJ_-SNQ..>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...